Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance — Stella

Home/Hyperlipidemia/

View on ClinicalTrials.gov

Recruiting

Back to Hyperlipidemia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

China

Department of Cardiology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi

The First Affiliated Hospital of Xi 'an Jiaotong University, Xi'an

Key details

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Enrollment target

~128 participants

Started

November 2024

Primary completion

November 2026

Age range

18 Years – 75 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.